Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. 1978

S Iwanaga, and T Morita, and T Harada, and S Nakamura, and M Niwa, and K Takada, and T Kimura, and S Sakakibara

An endotoxin-activated hemocyte lysate from the horseshoe crab (Tachypleus and Limulus) was found to hydrolyze Bz-Ile-Glu-(gamma-OR)-Gly-Arg-p-nitroanilide (PNA), Bz-Val-Gly-Arg-PNA, Boc-Val-Leu-Gly-Arg-PNA, and Boc-Leu-Gly-Arg-PNA, all of which have the COOH-terminal Gly-Arg sequence. This amidase activity was due to a clottting enzyme contained in the lysate. Furthermore, the amidase activity increased by increasing the concentration of bacterial endotoxin (E. coli, 0111-B4) added to the lysate. Therefore, the measurement of the endotoxin-induced amidase activity made it possible to determine the concentration of the endotoxin.

UI MeSH Term Description Entries
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D006737 Horseshoe Crabs An arthropod subclass (Xiphosura) comprising the North American (Limulus) and Asiatic (Tachypleus) genera of horseshoe crabs. Crabs, Horseshoe,Limulus,Limulus polyphemus,Tachypleus,Xiphosura,Crab, Horseshoe,Horseshoe Crab,Xiphosuras
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000991 Antithrombins Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. Antithrombin,Direct Antithrombin,Direct Antithrombins,Direct Thrombin Inhibitor,Direct Thrombin Inhibitors,Antithrombin, Direct,Antithrombins, Direct,Inhibitor, Direct Thrombin,Thrombin Inhibitor, Direct,Thrombin Inhibitors, Direct
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator

Related Publications

S Iwanaga, and T Morita, and T Harada, and S Nakamura, and M Niwa, and K Takada, and T Kimura, and S Sakakibara
July 1982, Thrombosis research,
S Iwanaga, and T Morita, and T Harada, and S Nakamura, and M Niwa, and K Takada, and T Kimura, and S Sakakibara
January 1978, Haemostasis,
S Iwanaga, and T Morita, and T Harada, and S Nakamura, and M Niwa, and K Takada, and T Kimura, and S Sakakibara
April 1980, Der Internist,
S Iwanaga, and T Morita, and T Harada, and S Nakamura, and M Niwa, and K Takada, and T Kimura, and S Sakakibara
January 1981, Thrombosis research,
S Iwanaga, and T Morita, and T Harada, and S Nakamura, and M Niwa, and K Takada, and T Kimura, and S Sakakibara
May 2016, Journal of inorganic biochemistry,
S Iwanaga, and T Morita, and T Harada, and S Nakamura, and M Niwa, and K Takada, and T Kimura, and S Sakakibara
June 1980, Thrombosis and haemostasis,
S Iwanaga, and T Morita, and T Harada, and S Nakamura, and M Niwa, and K Takada, and T Kimura, and S Sakakibara
October 1978, Comprehensive therapy,
S Iwanaga, and T Morita, and T Harada, and S Nakamura, and M Niwa, and K Takada, and T Kimura, and S Sakakibara
October 2002, The Journal of biological chemistry,
S Iwanaga, and T Morita, and T Harada, and S Nakamura, and M Niwa, and K Takada, and T Kimura, and S Sakakibara
January 1985, Journal of parenteral science and technology : a publication of the Parenteral Drug Association,
S Iwanaga, and T Morita, and T Harada, and S Nakamura, and M Niwa, and K Takada, and T Kimura, and S Sakakibara
December 2019, Biological & pharmaceutical bulletin,
Copied contents to your clipboard!